Ceftriaxone and Dextrose in Duplex Container
Categoria
Ceftriaxone and Dextrose in Duplex Container Nombres de marca, Ceftriaxone and Dextrose in Duplex Container Analogos
Ceftriaxone and Dextrose in Duplex Container Marca los nombres de mezcla
Ceftriaxone and Dextrose in Duplex Container Formula quimica
C18H18N8O7S3
Ceftriaxone and Dextrose in Duplex Container RX enlace
http://www.rxlist.com/cgi/generic3/ceftriax.htm
Ceftriaxone and Dextrose in Duplex Container FDA hoja
Ceftriaxone and Dextrose in Duplex Container MSDS (hoja de seguridad de materiales)
Ceftriaxone and Dextrose in Duplex Container Sintesis de referencia
M. Montavon, R. Reiner, Brit. pat. Appl. 2.022.090; Eidem, EE.UU. Pat. 4.327.210 (1979, 1982, tanto a Hoffmann-La Roche)
Ceftriaxone and Dextrose in Duplex Container Peso molecular
554.583 g/mol
Ceftriaxone and Dextrose in Duplex Container Punto de fusion
>155 oC
Ceftriaxone and Dextrose in Duplex Container H2O Solubilidad
No hay información disponible
Ceftriaxone and Dextrose in Duplex Container Estado
Solid
Ceftriaxone and Dextrose in Duplex Container LogP
-1.341
Ceftriaxone and Dextrose in Duplex Container Formas de dosificacion
IM infusión;
Ceftriaxone and Dextrose in Duplex Container Indicacion
Para el tratamiento de las infecciones (respiratorias, piel, tejidos blandos, infección del tracto urinario, ENT) causada por S. pneumoniae, H. influenzae, estafilococos, S. pyogenes (estreptococos del grupo A beta-hemolítico), E. coli, P. mirabilis, Klebsiella sp, estafilococos coagulasa negativos
Ceftriaxone and Dextrose in Duplex Container Farmacologia
La ceftriaxona es una cefalosporina / cefamicina beta-lactámicos antibióticos utilizados en el tratamiento de infecciones bacterianas causadas por sensibles, por lo general gram-positivos, los organismos. Ceftriaxona tiene actividad in vitro contra bacterias aeróbicas y anaeróbicas gram-positivas y gram-negativas. La actividad bactericida de los resultados de Ceftriaxona de la inhibición de la síntesis de la pared celular y es mediada a través de Ceftriaxona vinculante a las proteínas fijadoras de penicilina (PBP). La ceftriaxona es estable frente a la hidrólisis por una variedad de beta-lactamasas, incluidas las penicilinasas y cefalosporinasas y de amplio espectro beta lactamasas.
Ceftriaxone and Dextrose in Duplex Container Absorcion
No hay información disponible
Ceftriaxone and Dextrose in Duplex Container Toxicidad
No hay información disponible
Ceftriaxone and Dextrose in Duplex Container Informacion de Pacientes
Patient Information:
Patients should be counseled that antibacterial drugs including Ceftriaxone should only be used to
treat bacterial infections. They do not treat viral infections (eg, common cold). When Ceftriaxone
is prescribed to treat a bacterial infection, patients should be told that although it is common
to feel better early in the course of therapy, the medication should be taken exactly as directed.
Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of
the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and
will not be treatable by Ceftriaxone or other antibacterial drugs in the future.
Patients should be counseled that antibacterial drugs including Ceftriaxone should only be used to
treat bacterial infections. They do not treat viral infections (eg, common cold). When Ceftriaxone
is prescribed to treat a bacterial infection, patients should be told that although it is common
to feel better early in the course of therapy, the medication should be taken exactly as directed.
Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of
the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and
will not be treatable by Ceftriaxone or other antibacterial drugs in the future.
Ceftriaxone and Dextrose in Duplex Container Organismos afectados
Bacterias entéricas y otras eubacterias
